NOV 16, 2015 2:18 PM PST

Harnessing the Power of NK Cells to Fight Cancer

WRITTEN BY: Kara Marker
In the fight against cancer, immunotherapy is increasingly becoming a promising treatment option since it revolves around helping the body enhance its natural cancer-killing abilities. This week, scientists from the Institut de Recherches Cliniques de Montreal (IRCM) have discovered a new target for antibodies in immunotherapy development. 

Natural killer (NK) cells are lymphocytes that specialize in killing cancer cells. However, sometimes the action of NK cells is not enough to prevent the progression of cancer in the body. The group from IRCM looked to identify the mechanism behind the anti-cancer NK cell behavior with the idea of harnessing this action for use in immunotherapies. As described in their recent paper published in the Journal of Experimental Medicine, they finally discovered how an NK cell surface protein, DNAM-1, provided the stimulation behind the lymphocyte's cancer-killing tendencies. 
Various NK cell surface proteins

DNAM-1 competes with other surface receptors that might impede the cancer-killing action of NK cells. For example, the TIGIT receptor reduces NK cell efficiency. 

"When the TIGIT receptor interacts with an infected cell, it prevents its interaction with the DNAM-1 protein, which, as a result, suppresses the function of NK cells and slows the immune system," explained Dr. Andrew Veillette, leader of the IRCM study. 

As a cancer immunotherapy target, scientists could harness the action of DNAM-1 in the form of anti-TIGIT antibodies and other receptor blockers to enhance the natural cancer-fighting function of DNAM-1.

"This type of therapy could have a significant impact on the next generation of cancer treatments."

Watch the following video to learn more about different targets in the realm of cancer immunotherapy.
 
Source: IRCM
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUN 30, 2019
Cardiology
JUN 30, 2019
Opioid Addiction Comes With Increased Risk Of Infection
Public health officials have put decades of work into the battle against infectious diseases. Now, this progress is at risk of being dismantled. A recent s...
SEP 07, 2019
Immunology
SEP 07, 2019
A New Way To Fight Severe Peanut Allergies
Dr. Sandra Lin explains how SLIT is currently being used to treat allergies other than peanuts.    Over 1 million U.S. children have an allergy t...
SEP 14, 2019
Genetics & Genomics
SEP 14, 2019
DNA Construction Kit Could Drive Down Costs of Immune Therapy
Researchers at KU Leuven in Belgium have created a DNA construction kit that, when injected into muscle cells, enables sheep to produce new antibodies to f...
OCT 21, 2019
Drug Discovery & Development
OCT 21, 2019
Effective Vaccines for Lyme Disease?
Currently, there are no effective vaccines available for the presentation of Lyme disease. The only preventive efforts present includes “guiding&rdqu...
NOV 03, 2019
Genetics & Genomics
NOV 03, 2019
Can CRISPR Replace Antibiotics?
Antibiotic-resistant infections claim around 700,000 lives per year, with estimates saying that this number could swell to 10 million by 2050 (Jacobs: 2019...
JAN 16, 2020
Health & Medicine
JAN 16, 2020
Babies in Africa Receive World's First Malaria Vaccine
Would you accept a vaccine that was only 40% effective? For those at risk of malaria, the answer is likely a resounding, "yes!" According to the...
Loading Comments...